These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18712715)
1. A graphical device to represent the outcomes of a logistic regression analysis. Kranse R; Roobol M; Schröder FH Prostate; 2008 Nov; 68(15):1674-80. PubMed ID: 18712715 [TBL] [Abstract][Full Text] [Related]
2. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312 [TBL] [Abstract][Full Text] [Related]
4. Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice. Dong F; Kattan MW; Steyerberg EW; Jones JS; Stephenson AJ; Schröder FH; Klein EA J Urol; 2008 Jul; 180(1):150-4; discussion 154. PubMed ID: 18485398 [TBL] [Abstract][Full Text] [Related]
5. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. Chun FK; Karakiewicz PI; Briganti A; Walz J; Kattan MW; Huland H; Graefen M BJU Int; 2007 Apr; 99(4):794-800. PubMed ID: 17378842 [TBL] [Abstract][Full Text] [Related]
6. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Chun FK; Graefen M; Briganti A; Gallina A; Hopp J; Kattan MW; Huland H; Karakiewicz PI Eur Urol; 2007 May; 51(5):1236-40; discussion 1241-3. PubMed ID: 16945477 [TBL] [Abstract][Full Text] [Related]
7. [Nomogram as predictive model in clinical practice]. Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708 [TBL] [Abstract][Full Text] [Related]
8. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels. Ide H; Yasuda M; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S Anticancer Res; 2008; 28(4C):2487-92. PubMed ID: 18751439 [TBL] [Abstract][Full Text] [Related]
9. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174 [TBL] [Abstract][Full Text] [Related]
10. Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations. Roemeling S; Roobol MJ; Kattan MW; van der Kwast TH; Steyerberg EW; Schröder FH Cancer; 2007 Nov; 110(10):2218-21. PubMed ID: 17893906 [TBL] [Abstract][Full Text] [Related]
13. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy. Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280 [TBL] [Abstract][Full Text] [Related]
14. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Shariat SF; Karakiewicz PI; Suardi N; Kattan MW Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454 [TBL] [Abstract][Full Text] [Related]
15. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer. Nguyen CT; Zelefsky MJ; Kattan MW Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Davison BJ; Oliffe JL; Pickles T; Mroz L Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342 [TBL] [Abstract][Full Text] [Related]
17. Prostate cancer nomograms: an update. Chun FK; Karakiewicz PI; Briganti A; Gallina A; Kattan MW; Montorsi F; Huland H; Graefen M Eur Urol; 2006 Nov; 50(5):914-26; discussion 926. PubMed ID: 16935414 [TBL] [Abstract][Full Text] [Related]
18. External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets. Utsumi T; Kawamura K; Suzuki H; Kamiya N; Imamoto T; Miura J; Ueda T; Maruoka M; Sekita N; Mikami K; Ichikawa T Int J Urol; 2009 Apr; 16(4):416-9. PubMed ID: 19226358 [TBL] [Abstract][Full Text] [Related]
19. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer? Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341 [TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Kattan MW Eur Urol; 2008 Sep; 54(3):611. PubMed ID: 18207318 [No Abstract] [Full Text] [Related] [Next] [New Search]